In addition, epidemiological data have shown that obesity is a risk factor for postmenopausal breast cancer and exacerbates cancer progression, and the upregulation of S1P/S1PR1/STAT3 signaling has also been implicated in a mouse model of breast cancer associated with obesity [196]. Here, STAT3 is linked to obesity due to melanocortin 4 receptor deficiency.